Acquaintance of Botox: A cross-sectional survey among female students in Karachi, Pakistan

Abstract

The cosmetic treatment strategies have been considerably popular over the last few decades among the population with respect to age, gender, and ethnicity. These procedures are easily accessible safer, minimally invasive, and more precise. Botox therapy is one of the most common non-surgical cosmetic treatment. Thus, the current study was accomplished to assess the knowledge of female students towards Botox therapy for beautification as well as for therapeutic purposes. The study was conducted form June 2018 to December 2018 in different medical colleges and universities of Karachi-Pakistan. Overall, three hundred and eighty-six female students participated in the study. Descriptive statistics were used to reveal the students' demographic information. Pearson's chi-squared test was carried out to estimate the relationship between independent variables and responses. The response rate was 77.2%. The mean age of study participants was 26.44±3.33 years. The findings of the present study revealed that 58.3% of the participants were aware of Botox therapy and found it effective in cosmetology. The unexpected side effects, high procedure costs, and lack of cosmetologists were thought to be the main reasons that limit people from using Botox in Karachi-Pakistan.

Awareness of Botox Injections in Facial Aesthetics among Dental Students

“…In a study reported by E. M. Al Hamdan et al, Botox were commonly used to treat facial wrinkles [1]. Study reported by Imam et al showed that there was high awareness of people on Botox therapy and its effectiveness in cosmetology [6]. Therefore, this study is important to understand and increase the awareness of dentists on the use and the complications of Botox in facial aesthetics.…”

“…It was initially introduced by Alan Scott for treating crossed eyes and blepharospasm [1]. It is called a miracle poison, which is one of the most noxious natural substances to humans [6]. It was approved by the United States Food and Drug Administration in 2002 [7,8].…”